Company details

HEADCOUNT

1-24

ORG TYPE

Startup

SECTOR

Healthcare & Life Sciences

WEBSITE

http://www.orakl-oncology.com/

About the company

Orakl Oncology is a Paris-area TechBio spin-out building “patient tumor avatar” models, using patient-derived organoids plus clinical and molecular data to help biopharma predict trial outcomes and find better targets earlier. The company talks publicly about scaling lab automation alongside machine learning, with roles spanning wet lab, computational biology, and operations engineering. Orakl Oncology raised a reported €11m seed round in December 2024, following an earlier pre-seed round in 2023.

Locations and presence

Orakl Oncology hires around Le Kremlin-Bicêtre and Villejuif (Paris region), with roles commonly marked as occasional remote. The company positions the platform as partnered with oncology players and research hospitals, so the commercial footprint is global even if hiring is France-centered.

Palpable Score

60.7

/ 100

Orakl Oncology offers multiple credible early-career entry points for a 20ish-person startup, including internships that sit close to founders and core operations. The score is capped by limited public outcome evidence (progression, retention, reviews) and inconsistent pay transparency across roles.

Pillar 1: Early-career access

Score

14.7

/ 20

The company advertises multiple internships (Computational Biologist Intern, Operations Engineering Intern, Chief of Staff Intern) that are explicitly scoped as 6-month placements.
Orakl Oncology hires lab-facing roles that can suit earlier-career profiles (Lab Technician requiring a BSc or equivalent), not only senior scientists.
The company also posts senior hires (for example Senior Scientist, Senior ML Engineer), so early-career access exists but is not the full hiring mix.

Pillar 2: Hiring fairness and transparency

Score

15.3

/ 20

The company lays out a clear, time-bounded interview flow for internships: HR call, technical interview, then an in-person founder interview.
Orakl Oncology adds role-relevant assessment for lab hiring with a practical lab case focused on following protocols and working aseptically.
The company routes applications through a mainstream platform, but public pages do not consistently show timelines for decisions or feedback expectations after each stage.

Pillar 3: Learning and support

Score

12.7

/ 20

The company frames the Operations Engineering Intern role as working hand-in-hand with the CTO on real platform bottlenecks, which is strong “learn by shipping” exposure.
Orakl Oncology places interns in multidisciplinary settings where results are presented regularly to computational biology and wet-lab teams, supporting structured feedback loops.
The company does not publicly describe onboarding length, mentorship routines (1:1 cadence), or a training budget, so early-career support relies on manager quality rather than a visible system.

Pillar 4: Pay fairness and stability

Score

10.3

/ 20

The company’s main job pages often list “salary not specified”, which makes it hard for early-career candidates to judge fairness before applying.
Orakl Oncology has at least some external salary signals for the Lab Technician role (employer-provided ranges on major job platforms), plus equity-style benefits referenced as stock options.
The company does not show broad benefits detail (health cover, pension, learning budget) in a consistent way across listings, which limits confidence on overall compensation quality.

Pillar 5: Early-career outcomes

Score

7.7

/ 20

The company has very limited public employee-review coverage, so there is no reliable external read on early-career retention or manager quality.
Orakl Oncology publishes a company profile metric stating “turnover 0%”, but there is not enough context (time window, definition, team size effects) to treat this as a strong outcomes proof-point.
The company’s footprint is small enough that LinkedIn-style progression tracking is noisy, and there are no public examples of intern-to-full-time conversion or junior promotion pathways.